non pharmacological treatment for peptic ulcer disease

PEPTIC ULCER DISEASE potx

Ngày tải lên : 27/06/2014, 18:20

... on Peptic Ulcer 29 Wang G.Z. and Wang J.F. Chapter 3 Helicobacter Pylori Infection in Peptic Ulcer Disease 39 Tat-Kin Tsang and Manish Prasad Shrestha Chapter 4 NSAIDs and Peptic Ulcer Disease ... 2010). 3.3 Gastric acid secretion For decades, surgeons were taught and believed that peptic ulcer disease was caused by acid, since the cure rate of peptic ulcer disease by acid-reduction operations ... synergistically through pathways of inflammation in the development of ulcers and in ulcer bleeding (Figure 2). Peptic Ulcer Disease 28 Wallace, J.L.; McKnight, W.; Reuter, B.K. & Vergnolle...

500
509
0

Tài liệu Allergic and Non‐Allergic Sinusitis for the Primary Care Physician: Pathophysiology, Evaluation and Treatment pdf

Ngày tải lên : 19/02/2014, 08:20

... Whichrequireapproximately1week for regeneration B. Whichrequireapproximately6weeks for regeneration C. Whichrequireapproxi mately12weeks for regeneration D. Whichrequireapproximately6months for regeneration E. ... )was for children12years oryounger.(5‐7)Aprimarydiagnosisofacuteorchronicsinusitisaccounted for 58.7%ofallexpenditures($3.5 billion).(5‐7)Itisestimatedthat2.2billiondollarsisspentyearly onprescriptionandnonprescriptionmedication. (5‐7)About12%eachofthecosts for asthmaandchronicotitismediaand eustachiantubedisorderswere  45 Allergicand Non AllergicSinusitis for thePrimaryCarePhysician: Pathophysiology,Evaluationand Treatment  CHAPTER4 ALLERGYANDSINUS DISEASE INTRODUCTION AccordingtotheAmericanAcademyofAllergy,Asthma,andImmunology(AAAAI),over50million Americanssufferfromsomeformofallergiesthatgreatlyimpactstheirqualityoflifeaswellashealthcarecoststhat areestimatedatapproximately20billiondollarsayear.( 1)Allergicrhinitisaloneisestimatedtoaffect20to30 millionAmericanseachyearandaccounts for anestimated3%ofallmedicalofficevisitsandranksasthesecond mostcommonreasonpatientsseekprofessionalhealthcare.(1)InmanygeographicareasoftheUnitedStates, allergiesplay asignificantroleascontributoryfactorsofsinus disease aswellassecondarycauseofsinusinfections. Itisofgreatvaluetothepractitionertounderstandtheunderlyingimmunologicfactors,availablediagnostictests andtreatments.(2‐8) Itisespeciallyvaluable for thepractitionertobewellversedin allergybecausemanypatientsareconfused aboutthedifferencebetweensinusitis ... smoke,pollution,andother irritants.Surgicalcausesinclude anatomicabnormalitiessuchasadeviatedseptum,nasalpolyps,obstructedsinusesthatdonotimprovewith medication,over‐enlargedturbinates,obstructingadenoids,andothercauses.Sometimesscarringfromtraumaor  44 Allergicand Non AllergicSinusitis for thePrimaryCarePhysician: Pathophysiology,Evaluationand Treatment  CHAPTER3  QUESTIONS  1.Astronghistoryconsistentwithadiagnosisofchronicsinusitisincludesthepresenceof: A....

156
519
0

Hydroxyurea for the Treatment of Sickle Cell Disease docx

Ngày tải lên : 05/03/2014, 10:20

... hydroxyurea treatment for patients who have sickle cell disease? 2. What is the effectiveness (in everyday practice) of hydroxyurea treatment for patients who have sickle cell disease? 3. ... use of hydroxyurea for sickle cell disease. The dosing of hydroxyurea for sickle cell disease is comparable to that in other diseases, although in the case of malignant disease, more drug is ... adults with sickle cell disease; the evidence in other diseases was only low- grade. Barriers to the Use of Hydroxyurea and Other Treatments for Managing Sickle Cell Disease Only two studies...

298
1.1K
0

Báo cáo khoa học: The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer’s disease pptx

Ngày tải lên : 07/03/2014, 10:20

... as a therapeutic strategy for the treatment of Alzheimer’s disease Peter J. Crouch 1 , Anthony R. White 1 and Ashley I. Bush 2,3 1 Department of Pathology and Centre for Neuroscience, The University ... dysfunctional events characteristic of Alzheimer’s disease. Metal-based therapeutics have already provided promising results for the treatment of Alzheimer’s disease, and new generations of pharmaceuticals ... [75], may therefore repre- sent a potential therapeutic strategy for preventing the tau hyperphosphorylation and NFT formation characteristic of AD. Modulation of metal availability for treating...

9
634
0

KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) pdf

Ngày tải lên : 22/03/2014, 09:20

... considered in patients before treatment with bisphosphonates, because bone biopsy is the most accurate test for the diagnosis of adynamic bone disease, and the presence of adynamic bone disease is a contraindication ... especially in areas in which RCTs are feasible. EXCLUSION/INCLUSION CRITERIA FOR ARTICLE SELECTION FOR NONTREATMENT QUESTIONS For studies related to questions of diagnosis, prevalence, and natural ... than treatment targets. For the question related to parathyroidectomy vs medical management for secondary or tertiary hyperparathyroidism, a search was run for ‘parathyroidectomy’ and ‘kidney disease published...

140
777
1

báo cáo hóa học: " The effect of pharmacological treatment on gait biomechanics in peripheral arterial disease patients" pptx

Ngày tải lên : 19/06/2014, 08:20

... combina- tion treatment consisting of treadmill exercise and pharmacological treatment may be the most efficacious non- operative treatment for symptoms of PAD patients. Several limitations for this ... noted for the group as a whole with pharmacological treatment. However due to the large standard deviations (78.13 meters for pre -treatment and 162.19 meters for post- treatment) , there was no significant ... Differences as compared to healthy controls remained before and after standard treatment with FDA approved drugs. Therefore, such treatment for PAD does not translate to biomechanical gait changes...

9
475
0

Báo cáo khoa học: "Human vascular adhesion proteın-1 (VAP-1): Serum levels for hepatocellular carcinoma in non-alcoholic and alcoholic fatty liver disease" pdf

Ngày tải lên : 09/08/2014, 03:22

... cirrhosis, were selected for study. Of these, 33 patients had alcoholic liver disease and 22 patients non- alcoholic fatty liver disease. The diagnosis of non- alcoholic fatty liver disease cirrhosis ... and treatment and monitoring of diseases [9,12,16,17]. In this study, we aimed to demonstrate that sVAP-1 levels can be elevated in patients with alcoholic and non- alcoholic fatty liver diseases ... Access Human vascular adhesion proteın-1 (VAP-1): Serum levels for hepatocellular carcinoma in non- alcoholic and alcoholic fatty liver disease Ozgur Kemik 1* , Aziz Sümer 1 , Ahu Sarbay Kemik 2 ,...

4
294
0

Báo cáo y học: "The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases" pot

Ngày tải lên : 09/08/2014, 03:24

... now in use. This treatment is especially promising in autoimmune diseases characterized by a relapsing and remitting course such as SLE, inflammatory bowel disease or certain forms of multiple ... transferred noncloned CD4 + CD25 + cells protect lymphopenic mice from developing spontaneous organ- specific autoimmune diseases and also protect animals from developing graft-versus-host disease ... donor Commentary The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases David A Horwitz, J Dixon Gray and Song Guo Zheng The Division...

6
408
0

Báo cáo khoa học: " The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer" ppt

Ngày tải lên : 09/08/2014, 10:21

4
344
0

báo cáo khoa học: "Radical cyberknife radiosurgery with tumor tracking: an effective treatment for inoperable small peripheral stage I non-small cell lung cancer ppsx

Ngày tải lên : 10/08/2014, 22:20

9
290
0

Báo cáo y học: "Adalimumab - an effective and promising treatment for patients with fistulizing Crohn’s disease: a case series" pdf

Ngày tải lên : 11/08/2014, 00:23

6
350
0

Báo cáo y học: "Role of vasopressin in the treatment of anaphylactic shock in a child undergoing surgery for congenital heart disease: a case report" docx

Ngày tải lên : 11/08/2014, 11:20

4
370
0

Báo cáo y học: " Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): New Pharmacological Treatment Options for Crack-Cocaine Dependence in the Netherlands" doc

Ngày tải lên : 11/08/2014, 15:22

9
373
0

Báo cáo y học: " Internet-based treatment for older adults with depression and co-morbid cardiovascular disease: protocol for a randomised, double-blind, placebo controlled trial" ppt

Ngày tải lên : 11/08/2014, 16:22

10
315
0

Báo cáo y học: " The development of a knowledge test of depression and its treatment for patients suffering from non-psychotic depression: a psychometric assessment" ppt

Ngày tải lên : 11/08/2014, 17:20

15
416
0

$Báo cáo y học: " A new modality of treatment for non-united fracture of the humerus in a patient with osteopetrosis: a case report" pptx$

Báo cáo y học: " A new modality of treatment for non-united fracture of the humerus in a patient with osteopetrosis: a case report" pptx

Ngày tải lên : 11/08/2014, 19:21

3
298
0

Báo cáo y học: " A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: a staged highthroughput biophysical screening" pps

Ngày tải lên : 12/08/2014, 13:22

9
496
0

Báo cáo khoa học: "Herd and cow characteristics affecting the odds of veterinary treatment for disease – a multilevel analysis" pot

Ngày tải lên : 12/08/2014, 18:22

12
295
0

Báo cáo khoa học: "Medical treatment for the terminally ill: the ‘risk of unacceptable badness’"

Ngày tải lên : 25/10/2012, 10:45

... pain, suffering, and discomfort. The fundamental maxim for these patients should be comfort. Extraordinary life support for patients predicted to die does not equal comfort care. Competing interests The ... uncommon for physicians to ask loaded questions in their quest for end-of-life decisions. For example, ‘This is your grandmother’s 17th transfer from a skilled nursing facility in 3 months for sepsis ... discussions, we must strive for ‘consensus without consent’ [15]. Discussions with surrogates should strive for concordance and understanding but not extend to soliciting their consent for medically inappropriate...

2
463
0